| Code | Description | Claims | Beneficiaries | Total Paid |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
116,619 |
110,520 |
$13.74M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
113,898 |
104,285 |
$13.15M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
33,877 |
29,732 |
$8.79M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
60,674 |
56,359 |
$7.09M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
36,703 |
34,055 |
$4.09M |
| G0378 |
Hospital observation service, per hour |
15,405 |
12,849 |
$3.05M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,874 |
22,543 |
$2.13M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
17,538 |
16,654 |
$2.04M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
29,579 |
25,349 |
$1.56M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
13,338 |
12,802 |
$1.10M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
78,295 |
71,270 |
$738K |
| 80047 |
|
36,505 |
33,055 |
$726K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,811 |
3,525 |
$693K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,645 |
2,474 |
$649K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
21,072 |
7,706 |
$556K |
| J2357 |
Injection, omalizumab, 5 mg |
628 |
449 |
$533K |
| 95811 |
|
726 |
700 |
$515K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
654 |
607 |
$486K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,443 |
1,398 |
$439K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,236 |
2,039 |
$359K |
| 0002A |
|
3,956 |
3,789 |
$349K |
| 80053 |
Comprehensive metabolic panel |
21,247 |
16,612 |
$338K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,767 |
2,614 |
$319K |
| 80076 |
|
24,052 |
22,172 |
$318K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
20,227 |
17,738 |
$291K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,629 |
2,403 |
$260K |
| 84484 |
|
14,428 |
10,848 |
$257K |
| 0001A |
|
2,882 |
2,731 |
$250K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
330 |
328 |
$239K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,559 |
1,431 |
$233K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,859 |
1,710 |
$221K |
| 64483 |
|
288 |
261 |
$157K |
| 59025 |
Fetal non-stress test |
996 |
836 |
$155K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
144,883 |
128,902 |
$145K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
4,897 |
2,275 |
$132K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,574 |
1,506 |
$129K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
97 |
85 |
$125K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
88 |
80 |
$122K |
| 62323 |
|
285 |
262 |
$117K |
| 73564 |
|
1,523 |
1,226 |
$117K |
| 96402 |
|
489 |
384 |
$113K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
8,051 |
3,093 |
$111K |
| 93296 |
|
5,406 |
5,053 |
$97K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12,045 |
11,593 |
$96K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
136 |
134 |
$91K |
| 36415 |
Collection of venous blood by venipuncture |
33,074 |
28,128 |
$81K |
| 93798 |
|
1,099 |
178 |
$79K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,869 |
1,729 |
$74K |
| 0004A |
|
1,061 |
1,044 |
$73K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
119 |
111 |
$66K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,933 |
1,833 |
$62K |
| 81001 |
|
19,666 |
17,958 |
$60K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
327 |
194 |
$60K |
| 73610 |
|
824 |
731 |
$59K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
333 |
310 |
$57K |
| 95812 |
|
229 |
209 |
$51K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
41,160 |
35,959 |
$49K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
491 |
480 |
$45K |
| 97602 |
|
199 |
166 |
$43K |
| 73130 |
|
459 |
384 |
$40K |
| 73630 |
|
633 |
535 |
$38K |
| 73030 |
|
471 |
412 |
$38K |
| 96401 |
|
276 |
187 |
$37K |
| 93017 |
|
378 |
357 |
$36K |
| 52356 |
|
14 |
12 |
$33K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
276 |
181 |
$32K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
853 |
798 |
$30K |
| 87522 |
Neg quan hep c or qual rna |
527 |
491 |
$30K |
| 83605 |
|
1,048 |
903 |
$30K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,104 |
2,923 |
$30K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
59,680 |
55,015 |
$28K |
| J0248 |
Injection, remdesivir, 1 mg |
98 |
31 |
$24K |
| 97803 |
|
150 |
141 |
$23K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,977 |
1,874 |
$22K |
| 97802 |
|
127 |
118 |
$22K |
| 86769 |
|
520 |
509 |
$22K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
983 |
923 |
$20K |
| 82043 |
|
279 |
270 |
$20K |
| J3490 |
Unclassified drugs |
110,753 |
53,752 |
$19K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
24 |
24 |
$19K |
| 73502 |
|
237 |
215 |
$18K |
| 80320 |
|
190 |
173 |
$18K |
| 94726 |
|
235 |
224 |
$18K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,112 |
2,886 |
$17K |
| 80061 |
Lipid panel |
828 |
783 |
$17K |
| 88142 |
|
1,103 |
1,060 |
$16K |
| 85027 |
|
1,753 |
1,627 |
$12K |
| 93297 |
|
523 |
509 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
141 |
115 |
$11K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,530 |
8,958 |
$11K |
| 0064A |
|
144 |
142 |
$11K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
205 |
197 |
$11K |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
1,651 |
1,584 |
$10K |
| 84439 |
|
2,117 |
1,996 |
$10K |
| 0003A |
|
108 |
107 |
$10K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,020 |
4,481 |
$10K |
| 86140 |
|
279 |
269 |
$10K |
| 87081 |
|
4,189 |
3,925 |
$9K |
| 73110 |
|
101 |
83 |
$9K |
| 0124A |
|
263 |
258 |
$8K |
| 0012A |
|
94 |
89 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
666 |
628 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
22,528 |
19,892 |
$8K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
27 |
26 |
$8K |
| 87510 |
|
319 |
299 |
$7K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
89 |
62 |
$7K |
| 86850 |
|
203 |
188 |
$7K |
| 94060 |
|
177 |
171 |
$7K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
164 |
131 |
$7K |
| 72170 |
|
71 |
66 |
$6K |
| 72110 |
|
75 |
67 |
$6K |
| 0054A |
|
200 |
197 |
$6K |
| 87150 |
|
149 |
144 |
$6K |
| 96367 |
|
71 |
49 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
32 |
24 |
$6K |
| 81003 |
|
13,819 |
13,029 |
$6K |
| 94729 |
|
237 |
226 |
$5K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
173 |
165 |
$5K |
| 73100 |
|
72 |
61 |
$5K |
| 86256 |
|
117 |
112 |
$5K |
| 73562 |
|
100 |
85 |
$4K |
| 43235 |
|
14 |
14 |
$4K |
| 73140 |
|
50 |
41 |
$4K |
| 85610 |
|
822 |
761 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
9,243 |
8,496 |
$4K |
| 93299 |
|
173 |
159 |
$4K |
| 93971 |
|
16 |
15 |
$4K |
| 87660 |
|
319 |
299 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
11,618 |
9,657 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,688 |
5,286 |
$4K |
| 80143 |
|
36 |
28 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
152 |
139 |
$3K |
| 82784 |
|
146 |
141 |
$3K |
| 83690 |
|
11,844 |
10,916 |
$3K |
| 97165 |
|
40 |
40 |
$3K |
| Q0222 |
Injection, bebtelovimab, 175 mg |
31 |
31 |
$3K |
| 73501 |
|
58 |
50 |
$3K |
| 83516 |
|
71 |
67 |
$3K |
| 94010 |
|
63 |
55 |
$3K |
| 82746 |
|
90 |
90 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
2,570 |
2,338 |
$3K |
| 87340 |
|
172 |
166 |
$2K |
| 84480 |
|
366 |
342 |
$2K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
12 |
12 |
$2K |
| 81025 |
|
4,846 |
4,495 |
$2K |
| 80306 |
|
6,826 |
6,062 |
$2K |
| 84466 |
|
158 |
142 |
$2K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
56 |
55 |
$2K |
| 81511 |
|
26 |
26 |
$2K |
| 85652 |
|
309 |
298 |
$2K |
| 0071A |
|
19 |
19 |
$2K |
| 0072A |
|
18 |
18 |
$2K |
| 84156 |
|
281 |
270 |
$2K |
| C9399 |
Unclassified drugs or biologicals |
161 |
103 |
$2K |
| 86003 |
|
64 |
62 |
$2K |
| 86762 |
|
104 |
102 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
41 |
40 |
$2K |
| 0352U |
|
398 |
379 |
$2K |
| 0013A |
|
16 |
16 |
$2K |
| 80179 |
|
33 |
28 |
$2K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
150 |
144 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
17 |
13 |
$1K |
| 82607 |
|
109 |
104 |
$1K |
| 86780 |
|
139 |
132 |
$1K |
| 82248 |
|
173 |
164 |
$1K |
| 82728 |
|
253 |
232 |
$1K |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
16 |
12 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,501 |
2,412 |
$1K |
| 72190 |
|
12 |
12 |
$1K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
7,208 |
3,663 |
$1K |
| 88346 |
|
12 |
12 |
$1K |
| G0381 |
Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
28 |
26 |
$1K |
| 71250 |
|
12 |
12 |
$1K |
| A4649 |
Surgical supply; miscellaneous |
818 |
617 |
$1K |
| 83721 |
|
100 |
93 |
$1K |
| 73560 |
|
15 |
12 |
$1K |
| 86900 |
|
240 |
225 |
$989.12 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
19,069 |
17,313 |
$921.38 |
| 86592 |
|
83 |
80 |
$888.52 |
| 86703 |
|
37 |
37 |
$872.81 |
| 86304 |
|
49 |
40 |
$842.88 |
| 87902 |
|
17 |
12 |
$822.48 |
| 86706 |
|
74 |
70 |
$807.42 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,991 |
2,983 |
$784.44 |
| 93225 |
|
16 |
13 |
$758.19 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
35 |
25 |
$713.02 |
| 90686 |
|
15 |
14 |
$705.44 |
| 86704 |
|
41 |
39 |
$703.14 |
| 73620 |
|
16 |
15 |
$688.79 |
| 84436 |
|
194 |
187 |
$678.62 |
| 83540 |
|
158 |
142 |
$654.46 |
| 87480 |
|
319 |
299 |
$636.71 |
| 82103 |
|
13 |
12 |
$518.05 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
78 |
73 |
$517.66 |
| 86901 |
|
240 |
225 |
$492.72 |
| 85379 |
|
28 |
25 |
$411.60 |
| 87905 |
|
12 |
12 |
$410.24 |
| 86480 |
|
14 |
14 |
$375.62 |
| 82397 |
|
24 |
12 |
$375.50 |
| 87631 |
|
15 |
15 |
$346.10 |
| 84703 |
|
5,033 |
4,604 |
$313.48 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,213 |
4,892 |
$276.16 |
| 83615 |
|
164 |
127 |
$265.50 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
145 |
132 |
$242.30 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
623 |
505 |
$239.72 |
| 86376 |
|
13 |
12 |
$226.38 |
| 86708 |
|
27 |
25 |
$214.42 |
| 86160 |
|
29 |
28 |
$200.01 |
| Q3014 |
Telehealth originating site facility fee |
119 |
104 |
$193.78 |
| 86038 |
|
25 |
24 |
$173.45 |
| 36591 |
|
27 |
15 |
$162.93 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,177 |
1,092 |
$133.25 |
| 84550 |
|
43 |
41 |
$132.90 |
| 86803 |
|
25 |
25 |
$123.20 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,508 |
1,251 |
$119.87 |
| 82570 |
|
77 |
75 |
$85.85 |
| 82947 |
|
822 |
515 |
$81.36 |
| 82390 |
|
12 |
12 |
$45.77 |
| J2060 |
Injection, lorazepam, 2 mg |
493 |
393 |
$38.96 |
| 83735 |
|
434 |
382 |
$36.88 |
| 82077 |
|
543 |
471 |
$28.37 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
383 |
303 |
$27.97 |
| 87147 |
|
104 |
91 |
$22.22 |
| J2704 |
Injection, propofol, 10 mg |
9,921 |
5,839 |
$6.35 |
| J1630 |
Injection, haloperidol, up to 5 mg |
37 |
25 |
$4.74 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
1,517 |
768 |
$0.45 |
| 82565 |
|
79 |
74 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,260 |
1,217 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
175 |
158 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
173 |
156 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
33 |
25 |
$0.00 |
| 88313 |
|
12 |
12 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
151 |
115 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
93 |
69 |
$0.00 |
| A4314 |
Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) |
39 |
25 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
13 |
12 |
$0.00 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
13 |
13 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
60 |
42 |
$0.00 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
14 |
12 |
$0.00 |
| A4222 |
Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) |
39 |
25 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
48 |
40 |
$0.00 |
| A7002 |
Tubing, used with suction pump, each |
32 |
27 |
$0.00 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
31 |
12 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
12 |
12 |
$0.00 |
| 87186 |
|
14 |
12 |
$0.00 |
| 96376 |
|
319 |
247 |
$0.00 |
| C1769 |
Guide wire |
174 |
158 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
279 |
232 |
$0.00 |
| A4217 |
Sterile water/saline, 500 ml |
469 |
176 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
190 |
79 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
144 |
135 |
$0.00 |
| 88342 |
|
154 |
152 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
436 |
224 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
74 |
55 |
$0.00 |
| 88300 |
|
38 |
36 |
$0.00 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
12 |
12 |
$0.00 |
| 86308 |
|
41 |
39 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
114 |
106 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
28 |
27 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
43 |
43 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
45 |
40 |
$0.00 |
| 83880 |
|
16 |
13 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
15 |
15 |
$0.00 |
| 74420 |
|
16 |
12 |
$0.00 |
| 88304 |
|
16 |
16 |
$0.00 |
| 87077 |
|
18 |
16 |
$0.00 |